Cargando…
Outcomes of parenteral nutrition in patients with advanced cancer and malignant bowel obstruction
BACKGROUND: Malignant bowel obstruction (MBO) affects 3–15% of all cancer patients. In patients with advanced cancer and inoperable MBO, the average survival varies between four to nine weeks. Parenteral nutrition (PN) may improve survival in specific patient populations with malignant bowel obstruc...
Autores principales: | Velasquez, David A., Dhiman, Ankit, Brottman, Colette, Eng, Oliver S., Fenton, Emily, Herlitz, Jean, Lozano, Edward, McDonald, Edwin, Reynolds, Valerie, Wall, Elizabeth, Whitridge, Jeffrey, Semrad, Carol, Turaga, Kiran, Micic, Dejan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10680932/ https://www.ncbi.nlm.nih.gov/pubmed/38014195 http://dx.doi.org/10.21203/rs.3.rs-3455273/v1 |
Ejemplares similares
-
Risk factors for small bowel bleeding in an overt gastrointestinal bleeding presentation after negative upper and lower endoscopy
por: Micic, Dejan, et al.
Publicado: (2019) -
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: Where do we stand?
por: Witmer, Hunter D. D., et al.
Publicado: (2022) -
The Impact of COVID-19-Related Delays on Surgical Management of Peritoneal Surface Malignancies
por: Sood, Divya, et al.
Publicado: (2022) -
Double-balloon endoscopic management of iatrogenic perforation in the small bowel
por: Cordova, Jonathan, et al.
Publicado: (2016) -
Gall Bladder Disease and the Risk of Small Bowel Cancer—Results from a Nationwide Swedish Cohort Study
por: Emilsson, Louise, et al.
Publicado: (2022)